Ankylosing spondylitis
New over the counter painkiller “can be considered first-line option” for people with flaring joint pain
A new lipid formulation of low dose ibuprofen seems to work as well as a higher dose (prescription strength) standard ibuprofen, experts report in Osteoarthritis and Cartilage. Continue reading
My symptoms of ankylosing spondylitis were misdiagnosed as growing pains, with dire consequences for my long-term health – Ivan Charleton
Walking to school one morning when I was 13 years old, I felt a sharp pain in my left hip that never left me. Over my teenage years I saw many doctors, who all suggested I was experiencing growing pains. Continue reading
Secukinumab: promising new drug for ankylosing spondylitis
A drug – secukinumab – being explored as a treatment for ankylosing spondylitis showed sustained improvements in signs and symptoms of the condition in people who completed three years of treatment, according to data presented at the American College of Rheumatology Annual Meeting. Continue reading
Why did one-quarter of patients in one study stop taking their biosimilar? Subjective health complaints say experts
One-quarter (24%) of people who were switched from infliximab to a biosimilar version stopped taking the biosimilar due to health complaints during a six-month follow-up period, highlights research in Arthritis & Rheumatology. Continue reading
Devastating impact of arthritis across all aspects of society is highlighted in new campaign
The current and future impact of osteoarthritis and rheumatoid arthritis on the economy, the NHS, families and individuals is revealed in a campaign from Arthritis Research UK. Continue reading
